Mammalian manufacturing: focused on recombinant proteins and monocloncal antibodies
Our facility in Porriño, Spain is located 15 kilometers from Vigo (Pontevedra) and 110 kilometers from Porto, Portugal.
This clinical to commercial facility specializes in custom manufacturing of recombinant proteins and monoclonal antibodies; from ampoule thaw to final bulk drug substance. Lonza Porriño is a cGMP manufacturing site with a strong quality assurance and regulatory track record. We offer flexibility of scale and process and are compliant with cGMP, safety, health and environmental requirements.
Porriño is currently authorized as a commercial multi-product manufacturing site by AEMPS (Agencia Española de Medicamentos y Productos Sanitarios,) and has held a manufacturing license since 2004. The Porriño site manufactures a number of commercial products approved by the main regulatory agencies, such as EMA, FDA, Health Canada, PMDA (Japan), Swiss Medic, ANVISA (Brazil) and many others worldwide (Korea, Taiwan, Israel).